Division of Transfusion Medicine, Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Division of Transfusion Medicine, Department of Laboratory Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.
J Clin Apher. 2021 Dec;36(6):878-881. doi: 10.1002/jca.21939. Epub 2021 Sep 12.
Since vaccination for SARS-CoV-2 coronavirus started, the trajectory of patient numbers infected with the virus has improved once; however, variants of SARS-CoV-2 have emerged and more people have been infected; therefore, pandemic status is still far from resolution. Government and social efforts to prevent coronavirus infection continue in most states in the US and globally even after the Centers for Disease Control and Prevention declared some restriction relief for fully vaccinated people in March 2021. Healthcare institutions and various professional organizations have developed guidelines or policies to prevent the spread of these coronaviruses in the setting of apheresis. In this report, the issues that apheresis services may encounter under the current COVID-19 (SARS-CoV-2 coronavirus disease) pandemic will be discussed with potential strategies that can be adapted for efficient and optimum use of apheresis resources.
自开始接种 SARS-CoV-2 冠状病毒疫苗以来,感染该病毒的患者数量的轨迹有所改善;然而,SARS-CoV-2 的变体已经出现,更多的人被感染;因此,大流行状况仍远未得到解决。即使美国疾病控制与预防中心在 2021 年 3 月宣布对完全接种疫苗的人放宽一些限制,美国和全球大多数州的政府和社会仍在继续努力预防冠状病毒感染。医疗机构和各种专业组织制定了指南或政策,以防止在单采环境中这些冠状病毒的传播。在本报告中,将讨论单采服务在当前 COVID-19(SARS-CoV-2 冠状病毒病)大流行下可能遇到的问题,并提出可适应的潜在策略,以有效和最佳地利用单采资源。